Hyperglycemia in Acute COVID-19 is Characterized by Insulin Resistance and Adipose Tissue Infectivity by SARS-CoV-2. Reiterer et al.

Name: Hyperglycemia in Acute COVID-19 is Characterized by Insulin Resistance and Adipose Tissue Infectivity by SARS-CoV-2. Reiterer et al.
Creator: Moritz Reiterer
Published: 2021-09-10T20:35:44.980Z
Keywords: Metabolism

Reiterer, Moritz

doi:10.17632/sckg5ygndm.2

Hyperglycemia in Acute COVID-19 is Characterized by Insulin Resistance and Adipose Tissue Infectivity by SARS-CoV-2. Reiterer et al.

Published: 10 September 2021| Version 2 | DOI: 10.17632/sckg5ygndm.2

Contributor:

Moritz Reiterer

Description

Supplemental Data Files referenced in "Hyperglycemia in Acute COVID-19 is Characterized by Insulin Resistance and Adipose Tissue Infectivity by SARS-CoV-2" by Reiterer et al.

Hyperglycemia in Acute COVID-19 is Characterized by Insulin Resistance and Adipose Tissue Infectivity by SARS-CoV-2. Reiterer et al.

Description

Files

Categories

Licence